In this episode of ATTD 2025 Conference Catch-Up, we dive into Closed-Loop Control Systems: Advancements and Applications, featuring breakthrough discussions on the latest closed-loop systems, their impact on glycemic control, and the ongoing advancements aimed at improving accessibility and outcomes for individuals with type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Closed-loop from Diagnosis: What Have We Learned from the Longest-Ever Closed-Loop Study - Dr. Charlotte Boughton NAP @ Home: First Outpatient Studies of Neural-net Artificial Pancreas -Dr. Laya Ekhlaspour Cam APS FX in Very Young Children in Italy; 2-Year Follow-Up - Prof. Marco Marigliano How Do I See the Future of AID? - Prof. Roman Hovorka This episode is an essential listen for healthcare professionals and researchers in the field of diabetes care, looking to stay updated on the latest advancements in closed-loop insulin delivery systems, as well as their future potential for improving glycemic control and quality of life for patients with type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related